Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell H Rosner

Showing results (51-60 of 205) with videos related to

Pageof 21
Sort By:
Contributions to Nephrology|April 30, 2010
Dysnatremias in the intensive care unitMitchell H Rosner, Claudio Ronco
Contributions to Nephrology|June 1, 2011
Remote monitoring for the wearable artificial kidneyMitchell H Rosner, Claudio Ronco
Kidney360|April 4, 2022
GFR Measurement and Chemotherapy Dosing in Patients with Kidney Disease and CancerBlaithin A McMahon, Mitchell H Rosner
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2022
Drug-Induced Acute Kidney InjuryMark A Perazella, Mitchell H Rosner
Clinical Journal of the American Society of Nephrology : CJASN|August 11, 2012
Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemiaMitchell H Rosner, Alan C Dalkin
Kidney International|August 30, 2008
The mortality risk associated with higher hemoglobin: is the therapy to blame?Mitchell H Rosner, W Kline Bolton
Clinical Journal of the American Society of Nephrology : CJASN|February 22, 2018
Management of Severe Hyponatremia with Continuous Renal Replacement TherapiesMitchell H Rosner, Michael J Connor
Advances in Chronic Kidney Disease|December 24, 2013
Electrolyte disorders associated with cancerMitchell H Rosner, Alan C Dalkin
The New England Journal of Medicine|August 3, 2017
Acute Kidney Injury in Patients with CancerMitchell H Rosner, Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2018
Chimeric Antigen Receptor T Cell Therapy and the Kidney: What the Nephrologist Needs to KnowKenar D Jhaveri, Mitchell H Rosner
Pageof 21

Showing results (51-60 of 205) with videos related to

Sort By:
Pageof 21
Contributions to Nephrology|April 30, 2010
Dysnatremias in the intensive care unitMitchell H Rosner, Claudio Ronco
Contributions to Nephrology|June 1, 2011
Remote monitoring for the wearable artificial kidneyMitchell H Rosner, Claudio Ronco
Kidney360|April 4, 2022
GFR Measurement and Chemotherapy Dosing in Patients with Kidney Disease and CancerBlaithin A McMahon, Mitchell H Rosner
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2022
Drug-Induced Acute Kidney InjuryMark A Perazella, Mitchell H Rosner
Clinical Journal of the American Society of Nephrology : CJASN|August 11, 2012
Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemiaMitchell H Rosner, Alan C Dalkin
Kidney International|August 30, 2008
The mortality risk associated with higher hemoglobin: is the therapy to blame?Mitchell H Rosner, W Kline Bolton
Clinical Journal of the American Society of Nephrology : CJASN|February 22, 2018
Management of Severe Hyponatremia with Continuous Renal Replacement TherapiesMitchell H Rosner, Michael J Connor
Advances in Chronic Kidney Disease|December 24, 2013
Electrolyte disorders associated with cancerMitchell H Rosner, Alan C Dalkin
The New England Journal of Medicine|August 3, 2017
Acute Kidney Injury in Patients with CancerMitchell H Rosner, Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2018
Chimeric Antigen Receptor T Cell Therapy and the Kidney: What the Nephrologist Needs to KnowKenar D Jhaveri, Mitchell H Rosner
Pageof 21